Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.

Cramer RD, Patterson DE, Bunce JD.

J Am Chem Soc. 1988 Aug 1;110(18):5959-67. doi: 10.1021/ja00226a005. No abstract available.

PMID:
22148765
2.

Physical binding pocket induction for affinity prediction.

Langham JJ, Cleves AE, Spitzer R, Kirshner D, Jain AN.

J Med Chem. 2009 Oct 8;52(19):6107-25. doi: 10.1021/jm901096y.

3.
4.

Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.

Tanrikulu Y, Schneider G.

Nat Rev Drug Discov. 2008 Aug;7(8):667-77. doi: 10.1038/nrd2615. Epub 2008 Jul 18. Review.

PMID:
18636071
5.

Customizing scoring functions for docking.

Pham TA, Jain AN.

J Comput Aided Mol Des. 2008 May;22(5):269-86. doi: 10.1007/s10822-008-9174-y. Epub 2008 Feb 14.

6.

The trouble with QSAR (or how I learned to stop worrying and embrace fallacy).

Johnson SR.

J Chem Inf Model. 2008 Jan;48(1):25-6. Epub 2007 Dec 28.

PMID:
18161959
7.

Binding MOAD, a high-quality protein-ligand database.

Benson ML, Smith RD, Khazanov NA, Dimcheff B, Beaver J, Dresslar P, Nerothin J, Carlson HA.

Nucleic Acids Res. 2008 Jan;36(Database issue):D674-8. Epub 2007 Nov 30.

8.

Pushing the boundaries of 3D-QSAR.

Cramer RD, Wendt B.

J Comput Aided Mol Des. 2007 Jan-Mar;21(1-3):23-32. Epub 2007 Jan 26. Review.

PMID:
17253117
9.

Parameter estimation for scoring protein-ligand interactions using negative training data.

Pham TA, Jain AN.

J Med Chem. 2006 Oct 5;49(20):5856-68.

PMID:
17004701
10.

Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances.

Güner O, Clement O, Kurogi Y.

Curr Med Chem. 2004 Nov;11(22):2991-3005. Review.

PMID:
15544485
11.

Topomer CoMFA: a design methodology for rapid lead optimization.

Cramer RD.

J Med Chem. 2003 Jan 30;46(3):374-88.

PMID:
12540237
12.

Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships.

Johansson G, Sundquist S, Nordvall G, Nilsson BM, Brisander M, Nilvebrant L, Hacksell U.

J Med Chem. 1997 Nov 7;40(23):3804-19.

PMID:
9371246
13.

Antimuscarinic potency and bladder selectivity of PNU-200577, a major metabolite of tolterodine.

Nilvebrant L, Gillberg PG, Sparf B.

Pharmacol Toxicol. 1997 Oct;81(4):169-72.

PMID:
9353847
15.

3-(2-Benzofuranyl)quinuclidin-2-ene derivatives: novel muscarinic antagonists.

Nordvall G, Sundquist S, Johansson G, Glas G, Nilvebrant L, Hacksell U.

J Med Chem. 1996 Aug 16;39(17):3269-77.

PMID:
8765510
16.
17.
18.
19.

A shape-based machine learning tool for drug design.

Jain AN, Dietterich TG, Lathrop RH, Chapman D, Critchlow RE Jr, Bauer BE, Webster TA, Lozano-Perez T.

J Comput Aided Mol Des. 1994 Dec;8(6):635-52.

PMID:
7738601
20.

Supplemental Content

Support Center